Exploring the causal role of the human gut microbiome in breast cancer risk

Background The relationship between the human gut microbiome and breast cancer (BC) risk is uncertain. Methods We used Mendelian randomization (MR) and multivariable linear regression to investigate the causal relationship between the human gut microbiome and BC risk (overall and subtype-specific) and interrogate the role of circulating metabolites as potential mediators. Summary-level data from genome-wide association studies of gut microbial traits (N = 3,890), circulating metabolites (N = 7,824), overall (N = 247,175) and subtype-specific (N = 200,898) BC risk, including triple negative BC (TNBC; N = 120,493), alongside individual-level data from the Flemish Gut Flora Project (N = 2,242). Sensitivity analyses were applied to examine the robustness of causal estimates. Results Initial two-sample MR analyses suggested that the presence of bacteria within the Ruminococcus genus increased overall BC risk, that higher abundances of bacteria within the Parabacteroides genus decreased and presence of unclassified bacteria within the Bacteroidales order increased TNBC risk, and that several circulating metabolites altered BC risk (e.g., homostachydrine with overall BC and Luminal A BC, and betaine with TNBC). Whilst, in multivariable linear regression analyses, several of these metabolites were also associated with the microbial traits that influenced BC risk, given directional inconsistency of associations across analyses of microbial traits, metabolites and BC coupled with sensitivity analyses implying violations of MR assumptions, associations were unlikely to reflect causality nor a causal pathway between the gut microbiome, metabolites, and BC risk. Conclusions In conclusion, whilst our initial analyses suggested that the gut microbiome and certain circulating metabolites may be associated with BC risk, importantly, sensitivity analyses demonstrated that these relationships are complex and, certainly for the case of the gut microbiome, unlikely to reflect causality.

Authors

Institutions

Publication Details

Journal
Wellcome Open Research
Published
2026-10-28
DOI
https://doi.org/10.12688/wellcomeopenres.28010.1
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the causal role of the human gut microbiome in breast cancer risk

James Yarmolinsky, Jeroen Raes, Bryony L. Hayes, Jeremy P. Braybrooke et al.
6 links
Wellcome Open Research
Gut microbiota and health
article

Exploring the causal role of the human gut microbiome in breast cancer risk

James Yarmolinsky, Jeroen Raes, Bryony L. Hayes, Jeremy P. Braybrooke, Tim Robinson, Grace L. Edmunds, Nicholas John Timpson, Lara Gibbs, Kaitlin Hazel Wade, Matthew Lee, David Hughes
article en

Abstract

Background The relationship between the human gut microbiome and breast cancer (BC) risk is uncertain. Methods We used Mendelian randomization (MR) and multivariable linear regression to investigate the causal relationship between the human gut microbiome and BC risk (overall and subtype-specific) and interrogate the role of circulating metabolites as potential mediators. Summary-level data from genome-wide association studies of gut microbial traits (N = 3,890), circulating metabolites (N = 7,824), overall (N = 247,175) and subtype-specific (N = 200,898) BC risk, including triple negative BC (TNBC; N = 120,493), alongside individual-level data from the Flemish Gut Flora Project (N = 2,242). Sensitivity analyses were applied to examine the robustness of causal estimates. Results Initial two-sample MR analyses suggested that the presence of bacteria within the Ruminococcus genus increased overall BC risk, that higher abundances of bacteria within the Parabacteroides genus decreased and presence of unclassified bacteria within the Bacteroidales order increased TNBC risk, and that several circulating metabolites altered BC risk (e.g., homostachydrine with overall BC and Luminal A BC, and betaine with TNBC). Whilst, in multivariable linear regression analyses, several of these metabolites were also associated with the microbial traits that influenced BC risk, given directional inconsistency of associations across analyses of microbial traits, metabolites and BC coupled with sensitivity analyses implying violations of MR assumptions, associations were unlikely to reflect causality nor a causal pathway between the gut microbiome, metabolites, and BC risk. Conclusions In conclusion, whilst our initial analyses suggested that the gut microbiome and certain circulating metabolites may be associated with BC risk, importantly, sensitivity analyses demonstrated that these relationships are complex and, certainly for the case of the gut microbiome, unlikely to reflect causality.

Wellcome Open ResearchVol. 11
Pennington Biomedical Research Center (US), Rega Institute for Medical Research (BE), University of Bristol (GB), Centre international de recherche sur le cancer (FR), MRC Integrative Epidemiology Unit (GB), Imperial College London (GB), KU Leuven (BE)
Wellcome Trust, Cancer Research UK
Good health and well-being
Openalex Percentile: Top 22%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon